Pre-order Enquiry
Request Free Sample
Global Drugs for Treating Mental Disorders Market Research Report 2022
SKU ID : QYR-21414598 | Publishing Date : 03-Aug-2022 | No. of pages : 112
Detailed TOC of Global Drugs for Treating Mental Disorders Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Injection
1.2.5 Solution
1.2.6 Other
1.3 Market by Application
1.3.1 Global Drugs for Treating Mental Disorders Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Antipsychotics
1.3.3 Antidepressants
1.3.4 Antianxiety (Anxiolyitcs)
1.3.5 Anti-Seizure Medications
1.3.6 Stimulants
1.3.7 Cognitive Disorders And Dementia
1.3.8 Sleep Disorder Treatments
1.3.9 Substance Abuse Treatments
1.3.10 Hypnosis And Tranquilizers
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Treating Mental Disorders Market Perspective (2017-2028)
2.2 Drugs for Treating Mental Disorders Growth Trends by Region
2.2.1 Drugs for Treating Mental Disorders Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Treating Mental Disorders Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Treating Mental Disorders Market Dynamics
2.3.1 Drugs for Treating Mental Disorders Industry Trends
2.3.2 Drugs for Treating Mental Disorders Market Drivers
2.3.3 Drugs for Treating Mental Disorders Market Challenges
2.3.4 Drugs for Treating Mental Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Treating Mental Disorders Players by Revenue
3.1.1 Global Top Drugs for Treating Mental Disorders Players by Revenue (2017-2022)
3.1.2 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Treating Mental Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Treating Mental Disorders Revenue
3.4 Global Drugs for Treating Mental Disorders Market Concentration Ratio
3.4.1 Global Drugs for Treating Mental Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Treating Mental Disorders Revenue in 2021
3.5 Drugs for Treating Mental Disorders Key Players Head office and Area Served
3.6 Key Players Drugs for Treating Mental Disorders Product Solution and Service
3.7 Date of Enter into Drugs for Treating Mental Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Treating Mental Disorders Breakdown Data by Type
4.1 Global Drugs for Treating Mental Disorders Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028)
5 Drugs for Treating Mental Disorders Breakdown Data by Application
5.1 Global Drugs for Treating Mental Disorders Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Treating Mental Disorders Market Size (2017-2028)
6.2 North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
6.3 North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Drugs for Treating Mental Disorders Market Size (2017-2028)
7.2 Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
8.3 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Drugs for Treating Mental Disorders Market Size (2017-2028)
9.2 Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
9.3 Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
10.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Introduction
11.1.4 Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.1.5 Johnson and Johnson Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Treating Mental Disorders Introduction
11.2.4 Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Introduction
11.3.4 Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Introduction
11.4.4 GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Introduction
11.5.4 AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.5.5 AstraZeneca Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Introduction
11.6.4 Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Detail
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.7.4 Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Detail
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.8.5 Dr. Reddy's Laboratories Recent Development
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Detail
11.9.2 Apotex Inc. Business Overview
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Introduction
11.9.4 Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.9.5 Apotex Inc. Recent Development
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Detail
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.10.5 Mylan Pharmaceuticals Recent Development
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Detail
11.11.2 Par Pharmaceutical Business Overview
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.11.4 Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.11.5 Par Pharmaceutical Recent Development
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Detail
11.12.2 Aurobindo Pharma Business Overview
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Introduction
11.12.4 Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.12.5 Aurobindo Pharma Recent Development
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Detail
11.13.2 Torrent Pharmaceuticals Business Overview
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.13.4 Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.13.5 Torrent Pharmaceuticals Recent Development
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Detail
11.14.2 Jubilant Lifesciences Business Overview
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Introduction
11.14.4 Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.14.5 Jubilant Lifesciences Recent Development
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Detail
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.15.4 Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.15.5 Sun Pharmaceutical Recent Development
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Detail
11.16.2 Sandoz (Novartis) Business Overview
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Introduction
11.16.4 Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.16.5 Sandoz (Novartis) Recent Development
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Detail
11.17.2 Hansoh Pharmaceutical Business Overview
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.17.4 Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.17.5 Hansoh Pharmaceutical Recent Development
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Detail
11.18.2 WATSON Pharmaceuticals Business Overview
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.18.4 WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.18.5 WATSON Pharmaceuticals Recent Development
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Detail
11.19.2 Zhejiang Langhua Pharmaceuticals Business Overview
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.19.4 Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.19.5 Zhejiang Langhua Pharmaceuticals Recent Development
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Detail
11.20.2 Forest Laboratories Business Overview
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Introduction
11.20.4 Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.20.5 Forest Laboratories Recent Development
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Detail
11.21.2 H.Lundbeck A/S Business Overview
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Introduction
11.21.4 H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.21.5 H.Lundbeck A/S Recent Development
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Detail
11.22.2 Amneal Pharmaceuticals Business Overview
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.22.4 Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.22.5 Amneal Pharmaceuticals Recent Development
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Detail
11.23.2 Hetero Drugs Business Overview
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Introduction
11.23.4 Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.23.5 Hetero Drugs Recent Development
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Detail
11.24.2 Macleods Pharmaceuticals Business Overview
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.24.4 Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.24.5 Macleods Pharmaceuticals Recent Development
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Detail
11.25.2 Silarx Pharmacueticals Business Overview
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Introduction
11.25.4 Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.25.5 Silarx Pharmacueticals Recent Development
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Detail
11.26.2 Hikma Pharmaceuticals Business Overview
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.26.4 Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.26.5 Hikma Pharmaceuticals Recent Development
11.27 Lupin Limited
11.27.1 Lupin Limited Company Detail
11.27.2 Lupin Limited Business Overview
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Introduction
11.27.4 Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.27.5 Lupin Limited Recent Development
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Detail
11.28.2 Prinston Pharmaceutical Business Overview
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.28.4 Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.28.5 Prinston Pharmaceutical Recent Development
11.29 STI Pharma
11.29.1 STI Pharma Company Detail
11.29.2 STI Pharma Business Overview
11.29.3 STI Pharma Drugs for Treating Mental Disorders Introduction
11.29.4 STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.29.5 STI Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Drugs for Treating Mental Disorders Market Research Report 2022
List of TablesTable 1. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Injection
Table 5. Key Players of Solution
Table 6. Key Players of Other
Table 7. Global Drugs for Treating Mental Disorders Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Drugs for Treating Mental Disorders Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Drugs for Treating Mental Disorders Market Share by Region (2017-2022)
Table 11. Global Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Drugs for Treating Mental Disorders Market Share by Region (2023-2028)
Table 13. Drugs for Treating Mental Disorders Market Trends
Table 14. Drugs for Treating Mental Disorders Market Drivers
Table 15. Drugs for Treating Mental Disorders Market Challenges
Table 16. Drugs for Treating Mental Disorders Market Restraints
Table 17. Global Drugs for Treating Mental Disorders Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Drugs for Treating Mental Disorders Market Share by Players (2017-2022)
Table 19. Global Top Drugs for Treating Mental Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2021)
Table 20. Ranking of Global Top Drugs for Treating Mental Disorders Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Drugs for Treating Mental Disorders Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drugs for Treating Mental Disorders Product Solution and Service
Table 24. Date of Enter into Drugs for Treating Mental Disorders Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2017-2022)
Table 28. Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2023-2028)
Table 30. Global Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Drugs for Treating Mental Disorders Revenue Market Share by Application (2017-2022)
Table 32. Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Drugs for Treating Mental Disorders Revenue Market Share by Application (2023-2028)
Table 34. North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 44. Johnson and Johnson Company Detail
Table 45. Johnson and Johnson Business Overview
Table 46. Johnson and Johnson Drugs for Treating Mental Disorders Product
Table 47. Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 48. Johnson and Johnson Recent Development
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Drugs for Treating Mental Disorders Product
Table 52. Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Eli Lilly Company Detail
Table 55. Eli Lilly Business Overview
Table 56. Eli Lilly Drugs for Treating Mental Disorders Product
Table 57. Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 58. Eli Lilly Recent Development
Table 59. GlaxoSmithKline Company Detail
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline Drugs for Treating Mental Disorders Product
Table 62. GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 63. GlaxoSmithKline Recent Development
Table 64. AstraZeneca Company Detail
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Drugs for Treating Mental Disorders Product
Table 67. AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Bristol-Myers Squibb Company Detail
Table 70. Bristol-Myers Squibb Business Overview
Table 71. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product
Table 72. Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 73. Bristol-Myers Squibb Recent Development
Table 74. Teva Pharmaceutical Company Detail
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Drugs for Treating Mental Disorders Product
Table 77. Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Dr. Reddy's Laboratories Company Detail
Table 80. Dr. Reddy's Laboratories Business Overview
Table 81. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product
Table 82. Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 83. Dr. Reddy's Laboratories Recent Development
Table 84. Apotex Inc. Company Detail
Table 85. Apotex Inc. Business Overview
Table 86. Apotex Inc. Drugs for Treating Mental Disorders Product
Table 87. Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 88. Apotex Inc. Recent Development
Table 89. Mylan Pharmaceuticals Company Detail
Table 90. Mylan Pharmaceuticals Business Overview
Table 91. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 92. Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 93. Mylan Pharmaceuticals Recent Development
Table 94. Par Pharmaceutical Company Detail
Table 95. Par Pharmaceutical Business Overview
Table 96. Par Pharmaceutical Drugs for Treating Mental DisordersProduct
Table 97. Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 98. Par Pharmaceutical Recent Development
Table 99. Aurobindo Pharma Company Detail
Table 100. Aurobindo Pharma Business Overview
Table 101. Aurobindo Pharma Drugs for Treating Mental DisordersProduct
Table 102. Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 103. Aurobindo Pharma Recent Development
Table 104. Torrent Pharmaceuticals Company Detail
Table 105. Torrent Pharmaceuticals Business Overview
Table 106. Torrent Pharmaceuticals Drugs for Treating Mental DisordersProduct
Table 107. Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 108. Torrent Pharmaceuticals Recent Development
Table 109. Jubilant Lifesciences Company Detail
Table 110. Jubilant Lifesciences Business Overview
Table 111. Jubilant Lifesciences Drugs for Treating Mental DisordersProduct
Table 112. Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 113. Jubilant Lifesciences Recent Development
Table 114. Sun Pharmaceutical Company Detail
Table 115. Sun Pharmaceutical Business Overview
Table 116. Sun Pharmaceutical Drugs for Treating Mental DisordersProduct
Table 117. Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 118. Sun Pharmaceutical Recent Development
Table 119. Sandoz (Novartis) Company Detail
Table 120. Sandoz (Novartis) Business Overview
Table 121. Sandoz (Novartis) Drugs for Treating Mental DisordersProduct
Table 122. Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 123. Sandoz (Novartis) Recent Development
Table 124. Hansoh Pharmaceutical Company Detail
Table 125. Hansoh Pharmaceutical Business Overview
Table 126. Hansoh Pharmaceutical Drugs for Treating Mental DisordersProduct
Table 127. Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 128. Hansoh Pharmaceutical Recent Development
Table 129. WATSON Pharmaceuticals Company Detail
Table 130. WATSON Pharmaceuticals Business Overview
Table 131. WATSON Pharmaceuticals Drugs for Treating Mental DisordersProduct
Table 132. WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 133. WATSON Pharmaceuticals Recent Development
Table 134. Zhejiang Langhua Pharmaceuticals Company Detail
Table 135. Zhejiang Langhua Pharmaceuticals Business Overview
Table 136. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental DisordersProduct
Table 137. Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 138. Zhejiang Langhua Pharmaceuticals Recent Development
Table 139. Forest Laboratories Company Detail
Table 140. Forest Laboratories Business Overview
Table 141. Forest Laboratories Drugs for Treating Mental DisordersProduct
Table 142. Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 143. Forest Laboratories Recent Development
Table 144. H.Lundbeck A/S Company Detail
Table 145. H.Lundbeck A/S Business Overview
Table 146. H.Lundbeck A/S Drugs for Treating Mental DisordersProduct
Table 147. H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 148. H.Lundbeck A/S Recent Development
Table 149. Amneal Pharmaceuticals Company Detail
Table 150. Amneal Pharmaceuticals Business Overview
Table 151. Amneal Pharmaceuticals Drugs for Treating Mental DisordersProduct
Table 152. Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 153. Amneal Pharmaceuticals Recent Development
Table 154. Hetero Drugs Company Detail
Table 155. Hetero Drugs Business Overview
Table 156. Hetero Drugs Drugs for Treating Mental DisordersProduct
Table 157. Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 158. Hetero Drugs Recent Development
Table 159. Macleods Pharmaceuticals Company Detail
Table 160. Macleods Pharmaceuticals Business Overview
Table 161. Macleods Pharmaceuticals Drugs for Treating Mental DisordersProduct
Table 162. Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 163. Macleods Pharmaceuticals Recent Development
Table 164. Silarx Pharmacueticals Company Detail
Table 165. Silarx Pharmacueticals Business Overview
Table 166. Silarx Pharmacueticals Drugs for Treating Mental DisordersProduct
Table 167. Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 168. Silarx Pharmacueticals Recent Development
Table 169. Hikma Pharmaceuticals Company Detail
Table 170. Hikma Pharmaceuticals Business Overview
Table 171. Hikma Pharmaceuticals Drugs for Treating Mental DisordersProduct
Table 172. Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 173. Hikma Pharmaceuticals Recent Development
Table 174. Lupin Limited Company Detail
Table 175. Lupin Limited Business Overview
Table 176. Lupin Limited Drugs for Treating Mental DisordersProduct
Table 177. Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 178. Lupin Limited Recent Development
Table 179. Prinston Pharmaceutical Company Detail
Table 180. Prinston Pharmaceutical Business Overview
Table 181. Prinston Pharmaceutical Drugs for Treating Mental DisordersProduct
Table 182. Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 183. Prinston Pharmaceutical Recent Development
Table 184. STI Pharma Company Detail
Table 185. STI Pharma Business Overview
Table 186. STI Pharma Drugs for Treating Mental DisordersProduct
Table 187. STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 188. STI Pharma Recent Development
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Treating Mental Disorders Market Share by Type: 2021 VS 2028
Figure 2. Tablets Features
Figure 3. Capsule Features
Figure 4. Injection Features
Figure 5. Solution Features
Figure 6. Other Features
Figure 7. Global Drugs for Treating Mental Disorders Market Share by Application in 2021 & 2028
Figure 8. Antipsychotics Case Studies
Figure 9. Antidepressants Case Studies
Figure 10. Antianxiety (Anxiolyitcs) Case Studies
Figure 11. Anti-Seizure Medications Case Studies
Figure 12. Stimulants Case Studies
Figure 13. Cognitive Disorders And Dementia Case Studies
Figure 14. Sleep Disorder Treatments Case Studies
Figure 15. Substance Abuse Treatments Case Studies
Figure 16. Hypnosis And Tranquilizers Case Studies
Figure 17. Other Case Studies
Figure 18. Drugs for Treating Mental Disorders Report Years Considered
Figure 19. Global Drugs for Treating Mental Disorders Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 20. Global Drugs for Treating Mental Disorders Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Drugs for Treating Mental Disorders Market Share by Region: 2021 VS 2028
Figure 22. Global Drugs for Treating Mental Disorders Market Share by Players in 2021
Figure 23. Global Top Drugs for Treating Mental Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2021)
Figure 24. The Top 10 and 5 Players Market Share by Drugs for Treating Mental Disorders Revenue in 2021
Figure 25. North America Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. North America Drugs for Treating Mental Disorders Market Share by Country (2017-2028)
Figure 27. United States Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Canada Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Europe Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Europe Drugs for Treating Mental Disorders Market Share by Country (2017-2028)
Figure 31. Germany Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Drugs for Treating Mental Disorders Market Share by Region (2017-2028)
Figure 39. China Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Latin America Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Latin America Drugs for Treating Mental Disorders Market Share by Country (2017-2028)
Figure 47. Mexico Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Drugs for Treating Mental Disorders Market Share by Country (2017-2028)
Figure 51. Turkey Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Johnson and Johnson Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 54. Pfizer Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 55. Eli Lilly Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 57. AstraZeneca Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 60. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 61. Apotex Inc. Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 62. Mylan Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 63. Par Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 64. Aurobindo Pharma Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 65. Torrent Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 66. Jubilant Lifesciences Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 67. Sun Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 68. Sandoz (Novartis) Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 69. Hansoh Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 70. WATSON Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 71. Zhejiang Langhua Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 72. Forest Laboratories Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 73. H.Lundbeck A/S Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 74. Amneal Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 75. Hetero Drugs Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 76. Macleods Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 77. Silarx Pharmacueticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 78. Hikma Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 79. Lupin Limited Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 80. Prinston Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 81. STI Pharma Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Keyplayers in Global Drugs for Treating Mental Disorders Market Research Report 2022
Johnson and JohnsonPfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz (Novartis)
Hansoh Pharmaceutical
WATSON Pharmaceuticals
Zhejiang Langhua Pharmaceuticals
Forest Laboratories
H.Lundbeck A/S
Amneal Pharmaceuticals
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Hikma Pharmaceuticals
Lupin Limited
Prinston Pharmaceutical
STI Pharma
Request Sample
Request Discount
